Device / Technology News

RSS

Bend Research, PATH and FhCMB develop new technology for thermostable vaccine production

Bend Research Inc., PATH, and Fraunhofer USA Center for Molecular Biotechnology (FhCMB) announce the development of a new technology for the production of thermostable vaccines. Utilizing novel formulation and spray-drying processing methods, the technology has enabled scientists at Bend Research, PATH, and FhCMB to develop a spray-dried influenza vaccine product that is stable at 50°C for over 2 months. The technology can also be applied to emerging influenza and other vaccines.

29 Nov 2012

SLU study to use various assays for new TB vaccine development

A pilot study at Saint Louis University Center for Vaccine Development could shape the future of tuberculosis vaccine research by developing tests to identify the most promising vaccine candidates to address this global health crisis.

29 Nov 2012

Blood test and gene sequencing combined to detect cancer

Scientists at the Johns Hopkins Kimmel Cancer Center have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence and find residual cancer left after surgery.

29 Nov 2012

Winnie Palmer Hospital for Women & Babies launches new blog for health and wellness

Winnie Palmer Hospital for Women & Babies is launching a new blog for health and wellness called According to Winnie, an informative and interactive online community where women can join conversations on healthcare, prevention and wellness, dieting, recipes, family health, and more.

29 Nov 2012

Childhood obesity risk can be predicted at birth

A simple formula can predict at birth a baby's likelihood of becoming obese in childhood, according to a study published today in the open access journal PLOS ONE.

29 Nov 2012

Fertility treatment auto-injector: an interview with Lai Chiu Tang, Senior Industrial Designer at Cambridge Consultants

During IVF treatment you will need to take certain drugs. For example, for IVF it will be Follicle Stimulating Hormones (FSH) which are used to stimulate the ovaries to produce a mature egg so that they can be fertilised externally and then put back into the womb.

29 Nov 2012

Preventive mammogram recommendations could result in missed cancer, study says

A new study has found that U.S. Preventive Services Task Force recommendations that women over 50 get mammograms only every two years -- instead of every year -- could result in missed breast cancer.

29 Nov 2012

Tufts University researchers demonstrate silk-based implantable optics

Tufts University School of Engineering researchers have demonstrated silk-based implantable optics that offer significant improvement in tissue imaging while simultaneously enabling photo thermal therapy, administering drugs and monitoring drug delivery. The devices also lend themselves to a variety of other biomedical functions.

29 Nov 2012

Toshiba offers courses for Aquilion PRIME and RXL CT systems

Providing customers with advanced training for their imaging technology, Toshiba America Medical Systems, Inc.'s Institute of Advanced Imaging in Irvine, Calif., offers courses for the Aquilion PRIME and Aquilion RXL CT systems.

29 Nov 2012

VTT develops new patient-safe management tool

For the purpose of improving patient safety, VTT Technical Research Centre of Finland has developed a new management model based on customer needs. All the actors taking part in the organizational activity in social and health care organizations play a key role in safety management - including the patient. Both in Finland and abroad, there is a clear need for the systematic improvement of patient safety. Patient safety cannot be improved by simply making new rules.

29 Nov 2012

Nearly 63,000 people visit online catch-up immunization scheduling tool

Children obtain protection against certain diseases by receiving vaccinations, but they commonly miss recommended times to receive these immunizations. Once a child falls behind, health care professionals typically have to construct a unique, personalized catch-up schedule for each child - often while the child waits in the treatment room.

29 Nov 2012

Vacuum-compatible Pilatus X-ray detector can now track nanoparticles

Microvesicles are smallest cell elements which are present in all body fluids and are different, depending on whether a person is healthy or sick. This could contribute to detecting numerous diseases, such as, e.g., carcinomas, at an early stage, and to treating them more efficiently. The problem is that the diameter of the relevant microvesicles generally lies below 100 nm, which makes them technically detectable, but their exact size and concentration hardly possible to determine. A new device is now to provide the metrological basis for these promising biomarkers.

29 Nov 2012

NACHC, American College of Physicians announce program to offer Medical Home Builder 2.0

The American College of Physicians (ACP) and the National Association of Community Health Centers (NACHC) announced today a national effort to help federally-qualified health centers (FQHCs) improve care by offering ACP's Medical Home Builder 2.0 at a discounted rate.

29 Nov 2012

WellStar Health System implements Xenex’s room disinfection system

WellStar Health System was the first to implement and is the only health system in metro-Atlanta using Xenex Healthcare Services' room disinfection system in its patient and operating rooms. A "green," mercury-free technology, the Xenex system is the fastest, safest and most effective method for the advanced cleaning of hospital rooms, scientifically proven to destroy all major classes of microorganisms that cause hospital acquired infections (HAIs), such as MRSA and Clostridium difficile (C. diff).

29 Nov 2012

FDA approves Velomedix’s IDE to expand design of VELOCITY trial for heart attack

Velomedix, Inc., a venture-backed medical device company advancing the field of therapeutic hypothermia, announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to expand the design of its VELOCITY pilot clinical trial.

29 Nov 2012

China's SFDA approves QIAGEN careHPV Test and instrument platform

QIAGEN N.V. today announced that China's State Food and Drug Administration (SFDA) has approved QIAGEN's careHPV Test and instrument platform.

From QIAGEN Manchester Limited 29 Nov 2012

NuFACE receives FDA clearance for Trinity Facial Toning Device

NuFACE is thrilled to announce the launch the FDA cleared Trinity Wrinkle Remover, a red light attachment for the NuFACE Trinity Facial Toning Device. The removable attachment is engineered with advanced LEDs to deliver a precise combination of red and infrared light therapy treatments to reduce full face wrinkles.

29 Nov 2012

Vermillion’s OVA1 diagnostic test effectively identifies early-stage ovarian cancer

Gynecologic Oncology, the prestigious medical journal of the Society for Gynecologic Oncology, has published the second prospective clinical study of OVA1 which demonstrated the positive performance of the multi-biomarker test in the triage of early-stage ovarian cancer.

29 Nov 2012

Macular pigment screener launched by Elektron Technology

Elektron Technology is launching a new, easy-to-use macular pigment screener (MPS II) that can quickly identify those most at risk of developing age-related macular degeneration (AMD).

28 Nov 2012

Chalmers researcher develops world's first implantable robotic arm controlled by thoughts

The world's first implantable robotic arm controlled by thoughts is being developed by Chalmers researcher Max Ortiz Catalan. The first operations on patients will take place this winter.

28 Nov 2012